• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同实验室常规临床实践中的非铜蓝蛋白结合铜

Non-ceruloplasmin-bound copper in routine clinical practice in different laboratories.

作者信息

Twomey Patrick J, Viljoen Adie, Reynolds Timothy M, Wierzbicki Anthony S

机构信息

Department of Clinical Biochemistry, The Ipswich Hospital, Ipswich IP4 5PD, UK.

出版信息

J Trace Elem Med Biol. 2008;22(1):50-3. doi: 10.1016/j.jtemb.2007.11.001. Epub 2008 Feb 19.

DOI:10.1016/j.jtemb.2007.11.001
PMID:18319140
Abstract

BACKGROUND

Copper is an essential nutrient but is toxic when the free form is in excess. Wilson's disease (WD) is an autosomal recessive disorder of copper excess. Its diagnosis is a challenge, especially in the absence of obvious neurological changes, or Kayser-Fleischer rings. Non-ceruloplasmin-bound copper is a calculated parameter devised for the investigation of patients who potentially have WD.

METHODS

We compared non-ceruloplasmin-bound copper from three different laboratories. We retrospectively reviewed paired ceruloplasmin and copper data and calculated non-ceruloplasmin-bound copper. Comparative statistics, linear regression, chi-square test and graphical techniques were employed to compare the data.

RESULTS

All three assays had negative results for over 20% of the non-ceruloplasmin-bound copper concentrations; this was not significantly different. However, there were statistically significant differences for the 97.5th percentile. When plotted against the ceruloplasmin and copper concentrations, significant differences existed for both the visual and linear regression data between the three different laboratories.

CONCLUSIONS

Non-ceruloplasmin-bound copper cut-offs may not be transferable between laboratories. Each laboratory should derive its own cut-offs for the 97.5th percentile, as there are differences due to assays, populations or both.

摘要

背景

铜是一种必需营养素,但游离形式过量时具有毒性。威尔逊病(WD)是一种常染色体隐性铜过量疾病。其诊断具有挑战性,尤其是在没有明显神经变化或凯泽-弗莱舍尔环的情况下。非铜蓝蛋白结合铜是为调查可能患有WD的患者而设计的一个计算参数。

方法

我们比较了来自三个不同实验室的非铜蓝蛋白结合铜。我们回顾性地分析了配对的铜蓝蛋白和铜数据,并计算了非铜蓝蛋白结合铜。采用比较统计、线性回归、卡方检验和图形技术对数据进行比较。

结果

所有三种检测方法对超过20%的非铜蓝蛋白结合铜浓度检测结果为阴性;这一差异无统计学意义。然而,第97.5百分位数存在统计学显著差异。当与铜蓝蛋白和铜浓度作图时,三个不同实验室之间的直观数据和线性回归数据均存在显著差异。

结论

非铜蓝蛋白结合铜的临界值可能无法在不同实验室之间通用。每个实验室都应得出自己的第97.5百分位数临界值,因为由于检测方法、人群或两者原因存在差异。

相似文献

1
Non-ceruloplasmin-bound copper in routine clinical practice in different laboratories.不同实验室常规临床实践中的非铜蓝蛋白结合铜
J Trace Elem Med Biol. 2008;22(1):50-3. doi: 10.1016/j.jtemb.2007.11.001. Epub 2008 Feb 19.
2
The copper/caeruloplasmin ratio in routine clinical practice in different laboratories.不同实验室在常规临床实践中的铜/铜蓝蛋白比值。
J Clin Pathol. 2009 Jan;62(1):60-3. doi: 10.1136/jcp.2007.055111.
3
The relationship between serum copper and ceruloplasmin in routine clinical practice.常规临床实践中血清铜与铜蓝蛋白之间的关系。
Int J Clin Pract. 2008 Mar;62(3):485-7. doi: 10.1111/j.1742-1241.2007.01643.x. Epub 2007 Nov 21.
4
[The onset of psychiatric disorders and Wilson's disease].[精神疾病与威尔逊氏病的发病]
Encephale. 2007 Dec;33(6):924-32. doi: 10.1016/j.encep.2006.08.009. Epub 2007 Sep 5.
5
Wilson's disease patients with normal ceruloplasmin levels.血清铜蓝蛋白水平正常的威尔逊病患者。
Turk J Pediatr. 1999 Jan-Mar;41(1):99-102.
6
A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit.肝豆状核变性的临床研究:埃及一家儿科肝病科的经验
Arab J Gastroenterol. 2011 Sep;12(3):125-30. doi: 10.1016/j.ajg.2011.07.007. Epub 2011 Aug 30.
7
Wilson's Disease: a challenge of diagnosis. The 5-year experience of a tertiary centre.威尔逊氏病:诊断的挑战。一家三级医疗中心的5年经验。
Rom J Gastroenterol. 2004 Sep;13(3):179-85.
8
Wilson's disease: Experience at a tertiary care hospital.威尔逊病:一家三级医疗机构的经验
J Coll Physicians Surg Pak. 2013 Jul;23(7):525-6.
9
Value of an enzymatic assay for the determination of serum ceruloplasmin.一种用于测定血清铜蓝蛋白的酶法检测的价值。
J Lab Clin Med. 2004 Dec;144(6):294-301. doi: 10.1016/j.lab.2004.08.005.
10
Analysis of clinical and biochemical spectrum of Wilson disease patients.肝豆状核变性患者的临床及生化特征分析
Indian J Pathol Microbiol. 2012 Jul-Sep;55(3):365-9. doi: 10.4103/0377-4929.101746.

引用本文的文献

1
A comparative analysis in monitoring 24-hour urinary copper in wilson disease: sampling on or off treatment?威尔逊病患者24小时尿铜监测的比较分析:治疗期间还是治疗后采样?
Orphanet J Rare Dis. 2025 Jan 21;20(1):33. doi: 10.1186/s13023-025-03545-2.
2
Trientine Tetrahydrochloride, From Bench to Bedside: A Narrative Review.四盐酸曲恩汀,从实验室到临床应用:一篇叙述性综述
Drugs. 2024 Dec;84(12):1509-1518. doi: 10.1007/s40265-024-02099-0. Epub 2024 Oct 17.
3
Wilson's Disease with Acute Hepatic Onset: How to Diagnose and Treat It.急性肝起病型威尔逊病:如何诊断与治疗
Children (Basel). 2024 Jan 6;11(1):68. doi: 10.3390/children11010068.
4
Biochemical diagnosis of Wilson's disease: an update.肝豆状核变性的生化诊断:最新进展
Adv Lab Med. 2022 Apr 26;3(2):103-125. doi: 10.1515/almed-2022-0020. eCollection 2022 Jun.
5
Monitoring of Copper in Wilson Disease.威尔逊病中铜的监测
Diagnostics (Basel). 2023 May 23;13(11):1830. doi: 10.3390/diagnostics13111830.
6
Secretion and uptake of copper via a small copper carrier in blood fluid.血液中通过小铜载体分泌和摄取铜。
Metallomics. 2022 Mar 25;14(3). doi: 10.1093/mtomcs/mfac006.
7
Calculated parameters for the diagnosis of Wilson disease.用于诊断威尔逊病的计算参数。
Singapore Med J. 2023 Mar;64(3):188-195. doi: 10.11622/smedj.2022019. Epub 2022 Feb 10.
8
Chelation therapy in liver diseases of childhood: Current status and response.儿童肝脏疾病中的螯合疗法:现状与反应
World J Hepatol. 2021 Nov 27;13(11):1552-1567. doi: 10.4254/wjh.v13.i11.1552.
9
Speciation of Serum Copper and Zinc-Binding High- and Low-Molecular Mass Ligands in Dairy Cows Using HPLC-ICP-MS Technique.采用 HPLC-ICP-MS 技术对奶牛血清铜锌结合高、低分子量配体进行种属分析。
Biol Trace Elem Res. 2022 Feb;200(2):591-599. doi: 10.1007/s12011-021-02666-6. Epub 2021 Mar 15.
10
Apoceruloplasmin: Abundance, Detection, Formation, and Metabolism.脱辅基血浆铜蓝蛋白:丰度、检测、形成及代谢
Biomedicines. 2021 Feb 25;9(3):233. doi: 10.3390/biomedicines9030233.